Added to YB: 2026-01-09
Pitch date: 2026-01-05
GUARD.ST [neutral]
Guard Therapeutics International AB (publ)
+2.71%
current return
Author Info
Liquidation stocks is focused on liquidation and wind downs of listed stocks. I cover USA, Canada, UK, Europe, Australia, NZL, Japan, Hong Kong and other countries. Sign up for the newsletter.
Company Info
Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, develops novel therapies for diseases with high unmet medical need, primarily focusing on various forms of kidney disease in Sweden.
Market Cap
SEK 30.3M
Pitch Price
SEK 1.36
Price Target
2.76 (+74%)
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.37
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Liquidations Newsletter - Potential Liquidations: Guard Therapeutics International AB
GUARD.ST (liquidation update): Clinical-stage biotech discontinued main kidney program, insufficient cash for other programs. Board conducting strategic review for merger/RTO; if unsuccessful will delist & liquidate. 3.46 SEK/share cash vs 2.76 SEK NAV book value. Liquidation value play.
Read full article (1 min)